Phenytoin Therapy for Junctional Epidermolysis Bullosa

Rhonda B. Rogers, Kim B. Yancey, Bruce S. Allen, Margaret F. Guill

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Junctional epidermolysis bullosa (JEB) is a recessively inherited mechanobullous disease characterized by neonatal onset of blisters, healing without scarring or milium formation, dystrophic nails, and internal involvement in some patients. Several treatment modalities have been tried, including systemic corticosteroids and oral vitamin E, but no form of therapy has been uniformly successful. We describe a patient with JEB treated with phenytoin, followed by improvement in his skin lesions.

Original languageEnglish (US)
Pages (from-to)925-926
Number of pages2
JournalArchives of Dermatology
Volume119
Issue number11
DOIs
StatePublished - Jan 1 1983

Fingerprint

Junctional Epidermolysis Bullosa
Phenytoin
Infant, Newborn, Diseases
Blister
Nails
Vitamin E
Cicatrix
Adrenal Cortex Hormones
Skin
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Dermatology

Cite this

Rogers, R. B., Yancey, K. B., Allen, B. S., & Guill, M. F. (1983). Phenytoin Therapy for Junctional Epidermolysis Bullosa. Archives of Dermatology, 119(11), 925-926. https://doi.org/10.1001/archderm.1983.01650350053015

Phenytoin Therapy for Junctional Epidermolysis Bullosa. / Rogers, Rhonda B.; Yancey, Kim B.; Allen, Bruce S.; Guill, Margaret F.

In: Archives of Dermatology, Vol. 119, No. 11, 01.01.1983, p. 925-926.

Research output: Contribution to journalArticle

Rogers, RB, Yancey, KB, Allen, BS & Guill, MF 1983, 'Phenytoin Therapy for Junctional Epidermolysis Bullosa', Archives of Dermatology, vol. 119, no. 11, pp. 925-926. https://doi.org/10.1001/archderm.1983.01650350053015
Rogers, Rhonda B. ; Yancey, Kim B. ; Allen, Bruce S. ; Guill, Margaret F. / Phenytoin Therapy for Junctional Epidermolysis Bullosa. In: Archives of Dermatology. 1983 ; Vol. 119, No. 11. pp. 925-926.
@article{342f289664eb4c098578877c6c4e8b23,
title = "Phenytoin Therapy for Junctional Epidermolysis Bullosa",
abstract = "Junctional epidermolysis bullosa (JEB) is a recessively inherited mechanobullous disease characterized by neonatal onset of blisters, healing without scarring or milium formation, dystrophic nails, and internal involvement in some patients. Several treatment modalities have been tried, including systemic corticosteroids and oral vitamin E, but no form of therapy has been uniformly successful. We describe a patient with JEB treated with phenytoin, followed by improvement in his skin lesions.",
author = "Rogers, {Rhonda B.} and Yancey, {Kim B.} and Allen, {Bruce S.} and Guill, {Margaret F.}",
year = "1983",
month = "1",
day = "1",
doi = "10.1001/archderm.1983.01650350053015",
language = "English (US)",
volume = "119",
pages = "925--926",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Phenytoin Therapy for Junctional Epidermolysis Bullosa

AU - Rogers, Rhonda B.

AU - Yancey, Kim B.

AU - Allen, Bruce S.

AU - Guill, Margaret F.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - Junctional epidermolysis bullosa (JEB) is a recessively inherited mechanobullous disease characterized by neonatal onset of blisters, healing without scarring or milium formation, dystrophic nails, and internal involvement in some patients. Several treatment modalities have been tried, including systemic corticosteroids and oral vitamin E, but no form of therapy has been uniformly successful. We describe a patient with JEB treated with phenytoin, followed by improvement in his skin lesions.

AB - Junctional epidermolysis bullosa (JEB) is a recessively inherited mechanobullous disease characterized by neonatal onset of blisters, healing without scarring or milium formation, dystrophic nails, and internal involvement in some patients. Several treatment modalities have been tried, including systemic corticosteroids and oral vitamin E, but no form of therapy has been uniformly successful. We describe a patient with JEB treated with phenytoin, followed by improvement in his skin lesions.

UR - http://www.scopus.com/inward/record.url?scp=0021081545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021081545&partnerID=8YFLogxK

U2 - 10.1001/archderm.1983.01650350053015

DO - 10.1001/archderm.1983.01650350053015

M3 - Article

VL - 119

SP - 925

EP - 926

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 11

ER -